Table S1. Patient demographics and baseline characteristics (ECLIPSE study). Table S2. Long-term outcomes based on single-component short-term CIDs (TORCH study; ITT population). (DOCX 110 kb
Weighted linear regression bubble plots for associations (study end) with percentage of rescue-free ...
Rank probability analysis of TC with using statins in COPD patients. (TIF 36014 kb
Table S1. Demographic data for those at baseline and final visit. Table S2. Comparison of baseline a...
Figure S1. Proportions of patients experiencing CIDs in the ECLIPSE study. (EPS 1962 kb
Association Between Biomarkers and COPD Outcomes. Table S2. Statistical Models. Table S3. Demographi...
Table S1. Demographics of patients without COPD. Table S2. Demographics of patients with COPD. Table...
Results tables for sensitivity analyses testing the assumptions made in the main analysis (as descri...
Tables S1-S4. Table S1. Time scale of when variables data collected according to index date (annual ...
Table S1. Baseline characteristics by treatment group for patients included in this analysis and for...
Forest plot showing effect of statins on heart disease-related mortality in COPD patients. (TIF 3953...
Additional file 1: Figure S1. Flowchart of patient selection. Table S1. Codes used for identificatio...
Table S1. Ten-Year CVD Risk by GOLD classification and selected baseline characteristics in COPD pat...
Table S1. Serum biomarkers in 2005, comparing subjects participating respectively alive but not part...
Correlations between HRQL instruments and with GOLD grade and BODE as clinical measures: Spearman Co...
Table S1. Characteristics of ECLIPSE Study COPD cases stratified by BMI category. Continuous variabl...
Weighted linear regression bubble plots for associations (study end) with percentage of rescue-free ...
Rank probability analysis of TC with using statins in COPD patients. (TIF 36014 kb
Table S1. Demographic data for those at baseline and final visit. Table S2. Comparison of baseline a...
Figure S1. Proportions of patients experiencing CIDs in the ECLIPSE study. (EPS 1962 kb
Association Between Biomarkers and COPD Outcomes. Table S2. Statistical Models. Table S3. Demographi...
Table S1. Demographics of patients without COPD. Table S2. Demographics of patients with COPD. Table...
Results tables for sensitivity analyses testing the assumptions made in the main analysis (as descri...
Tables S1-S4. Table S1. Time scale of when variables data collected according to index date (annual ...
Table S1. Baseline characteristics by treatment group for patients included in this analysis and for...
Forest plot showing effect of statins on heart disease-related mortality in COPD patients. (TIF 3953...
Additional file 1: Figure S1. Flowchart of patient selection. Table S1. Codes used for identificatio...
Table S1. Ten-Year CVD Risk by GOLD classification and selected baseline characteristics in COPD pat...
Table S1. Serum biomarkers in 2005, comparing subjects participating respectively alive but not part...
Correlations between HRQL instruments and with GOLD grade and BODE as clinical measures: Spearman Co...
Table S1. Characteristics of ECLIPSE Study COPD cases stratified by BMI category. Continuous variabl...
Weighted linear regression bubble plots for associations (study end) with percentage of rescue-free ...
Rank probability analysis of TC with using statins in COPD patients. (TIF 36014 kb
Table S1. Demographic data for those at baseline and final visit. Table S2. Comparison of baseline a...
DOI
Add to ORKG